Task: Answer the multiple choice question.
Query: Which drug exhibits a 5.474% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) O=C(NCc1ccc(C(F)(F)F)cc1)C1CC(c2c(Cl)cccc2Cl)=NO1
b) O=C(c1cc(-c2cccs2)on1)N1CCN(C(c2ccccc2)c2ccccc2)CC1
c) COc1ccc(-c2[nH]ncc2CN2CCC(OCc3cccnc3)CC2)c(F)c1
d) Cc1ccc(N2CC(C(=O)N3CCOCC3)CC2=O)cc1Cl
e) Cc1ccc(CN2C(=O)C(C)Nc3ncnc(N4CCN(c5ccccn5)CC4)c32)cc1.O=C(O)C(F)(F)F
Answer: d. Cc1ccc(N2CC(C(=O)N3CCOCC3)CC2=O)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(N2CC(C(=O)N3CCOCC3)CC2=O)cc1Cl
Cc1ccc(N2CC(C(=O)N3CCOCC3)CC2=O)cc1Cl
1-(3-chloro-4-methylphenyl)-4-(morpholine-4-carbonyl)pyrrolidin-2-one